Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.
Cancer Discov
; 12(12): 2754-2762, 2022 12 02.
Article
in En
| MEDLINE
| ID: mdl-36255231
Full text:
1
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Breast Neoplasms
/
Immunoconjugates
Limits:
Female
/
Humans
Language:
En
Journal:
Cancer Discov
Year:
2022
Type:
Article
Affiliation country:
Belgium